ResearcherNorth Sichuan Medical UniversityNo recent work listed

Wei Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0875-263X; OpenAlex author ID A5100441748. Sources: OpenAlex.

Their work

Papers: 3 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 1 paper

Papers 3

EZR Promotes Pancreatic Cancer Proliferation and Metastasis by Activating FAK/AKT Signaling Pathway First author DOI 10.21203/rs.3.rs-770494/v2 ↗
Identification of DNA methylation-driven genes by integrative analysis of DNA methylation and transcriptome data in pancreatic adenocarcinoma. Co-author DOI 10.3892/etm.2020.8554 ↗
Application of the High-throughput TAB-Array for the Discovery of Novel 5-Hydroxymethylcytosine Biomarkers in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/epigenomes3030016 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jian Xu · 1 shared paper, 2021 · strength 0.28
- Paper EZR Promotes Pancreatic Cancer Proliferation and Metastasis by Activating FAK/AKT Signaling Pathway DOI 10.21203/rs.3.rs-770494/v2 ↗
Xuexi Tang · 1 shared paper, 2020 · strength 0.13
- Paper Identification of DNA methylation-driven genes by integrative analysis of DNA methylation and transcriptome data in pan… DOI 10.3892/etm.2020.8554 ↗
Chang Zeng · 1 shared paper, 2019 · strength 0.11
- Paper Application of the High-throughput TAB-Array for the Discovery of Novel 5-Hydroxymethylcytosine Biomarkers in Pancreati… DOI 10.3390/epigenomes3030016 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.